APGE — Apogee Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Apogee Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	152	395	521	730
Prepaid Expenses
Total Other Current Assets
Total Current Assets	152	398	530	741
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	2.59	13.3	14.4
Long Term Investments
Other Long Term Assets
Total Assets	152	401	754	937
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	9.98	20.6	28.6	27.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.98	21.5	37.2	33.3
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	142	380	717	904
Total Liabilities & Shareholders' Equity	152	401	754	937
Total Common Shares Outstanding